Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C (Q43000127)
Jump to navigation
Jump to search
scientific article published on September 21, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C |
scientific article published on September 21, 2010 |
Statements
1 reference
Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C (English)
1 reference
Stefan Zeuzem
1 reference
Patrick Marcellin
1 reference
Rami Moucari
1 reference
Nicole Forestier
1 reference
Dominique Larrey
1 reference
Dominique Guyader
1 reference
Patrice Couzigou
1 reference
Yves Benhamou
1 reference
Michel Vidaud
1 reference
Scott Seiwert
1 reference
Bill Bradford
1 reference
21 September 2010
1 reference
1 reference
59
1 reference
12
1 reference
1694-1698
1 reference
Identifiers
1 reference
1 reference